The science of cardiac safety: centralized approach for Phase III studies enhances the quality and integrity of collected data

There is considerable interest in drug safety among multiple stakeholders in the United States, including the Food and Drug Administration (FDA), the National Institutes of Health, the Institute of Medicine [...]